๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical pharmacology of exogenously administered alkaline phosphatase

โœ Scribed by P. Pickkers; F. Snellen; P. Rogiers; J. Bakker; P. Jorens; J. Meulenbelt; H. Spapen; J. E. Tulleken; R. Lins; S. Ramael; M. Bulitta; J. G. van der Hoeven

Book ID
105921811
Publisher
Springer
Year
2008
Tongue
English
Weight
216 KB
Volume
65
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Clinical significance of serum high-mole
Clinical significance of serum high-molecular-mass alkaline phosphatase, alkaline phosphataseโ€“lipoprotein-X complex, and intestinal variant alkaline phosphatase
โœ Dr. Paul L. Wolf ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 1023 KB

## Abstract This paper is a study to identify the clinical significance of highโ€molecularโ€mass alkaline phosphatase (ALP:E:C.3.1.3.1.), ALPโ€“lipoproteinโ€“X complex (LPโ€X) and intestinal variant ALP. We used cellulose acetate and agarose gels and techniques including wheat germ lectin, cetavlonโ€diethy

Exogenous alkaline phosphatase for the t
Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis
โœ Milan Lukas; Pavel Drastich; Michal Konecny; Paolo Gionchetti; Ondrej Urban; Fra ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB

Background: Increased activity of intestinal alkaline phosphatase (AP) occurs locally in patients with ulcerative colitis (UC), aimed at repairing inflammatory tissue damage. We evaluated the safety and preliminary efficacy of exogenous AP administered to patients with UC in an open-label, first-in-